Covance takes biomarker biz further
Covance is seeing the high potential of the booming market for biomarkers and has decided to devote an entire expert team to support clients with biomarker-related services.
Covance is seeing the high potential of the booming market for biomarkers and has decided to devote an entire expert team to support clients with biomarker-related services.
Roche has continued its spring spending spree with the $56.5m (€42.2m) purchase of antibody research specialist Therapeutic Human Polyclonals (THP).
GE Healthcare and the Bio Affinity Company (BAC) have extended their biopharmaceutical partnership to develop purification media for Factor VIII (FVIII) for the treatment of haemophilia A.
Contract formulation firms are being increasingly relied upon to ease drug development bottlenecks being created by new drug discovery technologies.
A drug discovery collaboration between Ranbaxy and GlaxoSmithKline (GSK) is bearing fruit with the companies stepping up their respiratory inflammation research.
The Council of Europe has inaugurated new premises for its European Directorate for the Quality of Medicines & HealthCare (EDQM) in Strasbourg.
As Swiss firm Lonza announced last week that it has broken ground at its second manufacturing site in Singapore, the region looks set for growth in biologics manufacture with biological products due to take centre stage in the pharma industry over the...
Evotec is willing to accept significant losses, at least in the short term, as it moves from being solely a service provider, to having its own drug development programme as well.